Description
HIMS & HERS Q3 2025 Earnings: 49% Revenue Growth, Subscriber Surge, and Revolutionary Health Disruptions Ahead!
In this deep dive, we break down the latest shareholder letter highlights, from soaring cash flow and personalized treatments fueling a powerful flywheel, to price cuts on GLP-1s, new testosterone/menopause offerings, upcoming lab testing and longevity services, plus expansions into Europe and Canada. Discover why this could redefine healthcare and deliver massive investor returns—complete with charts and modeling.
If you're into smart investing, hit subscribe and turn on notifications for more breakdowns!
🎉 Join our brand-new Discord community — it’s free!
We’re building a fun, supportive space for like-minded investors to share their favorite stocks, ask questions, and help shape future video topics. Whether you're just getting started or deep into the markets, we’d love to have you.
👉 https://discord.gg/K4FhqPJ8Jt
Curious about how to invest? You’re in the right place. Whether you're just starting out or you're an experienced investor looking for in-depth stock market analysis and interviews — this channel is for you.
My mission is to provide extreme value through high-quality investing videos that are easy to understand yet rooted in proven, long-term strategies taught by legends like Peter Lynch and Warren Buffett. Every video is designed to help you invest smarter and build wealth with clarity and confidence.
👤 About Me:
I'm Jake — a lifelong learner, investor, and creator. I’m passionate about helping others make informed decisions and thrive in both traditional investing and the future of finance.
🔗 Connect with Me:
X (Twitter): https://x.com/HowToInvest_jb
Instagram: https://www.instagram.com/howtoinvest_jb/
TikTok: https://www.tiktok.com/@howtoinvest_jb?lang=en
Facebook: https://www.facebook.com/profile.php?id=61570167670768
🎥 My ""Top 10"" Channel: [youtube.com/@JakeBrowatzke](https://www.youtube.com/@JakeBrowatzke)
⚠️Disclaimer:
All videos on this channel are for educational and entertainment purposes only. I’m not a financial advisor, and nothing here is investment advice. While I strive to provide accurate and timely information, always do your own research before making any financial decisions. Your money, your responsibility. Invest smart — and stay safe out there!
Chapters:
0:00 Introduction to HIMS & HERS Q3 2025 Earnings
0:30 Revenue Growth, Cash Flow, and Subscriber Metrics
2:10 Personalized Treatment Plans and the Flywheel Effect
4:33 GLP-1 Price Reduction and Verticalization Benefits
5:17 New Testosterone and Menopause Offerings
7:54 Comprehensive Lab Testing Capabilities
9:07 Longevity Specialty Launch in 2026
12:12 Discussions with Novo Nordisk for GLP-1s
13:54 Verticalization, Expansion, and Peptides R&D
16:24 FDA-Registered Facilities Assurance
17:19 Replacing Primary Care Physicians
18:50 Zava Global Acquisition and European Expansion
19:34 Canada Expansion and Generic GLP-1s
20:17 Subscriber and Revenue Growth Trends
22:24 Financial Modeling and Future Projections
26:09 Conclusion and Final Thoughts